Management of Patients with Oral Candidiasis

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Standard

Management of Patients with Oral Candidiasis. / Kragelund, Camilla; Reibel, Jesper; Pedersen, Anne Marie Lynge.

Oral Infections and General Health : From Molecule to Chairside. ed. / Anne Marie Lynge Pedersen. 1. ed. Heidelberg : Springer, 2016. p. 137-144.

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Harvard

Kragelund, C, Reibel, J & Pedersen, AML 2016, Management of Patients with Oral Candidiasis. in AML Pedersen (ed.), Oral Infections and General Health : From Molecule to Chairside. 1 edn, Springer, Heidelberg, pp. 137-144. https://doi.org/10.1007/978-3-319-25091-5_13

APA

Kragelund, C., Reibel, J., & Pedersen, A. M. L. (2016). Management of Patients with Oral Candidiasis. In A. M. L. Pedersen (Ed.), Oral Infections and General Health : From Molecule to Chairside (1 ed., pp. 137-144). Springer. https://doi.org/10.1007/978-3-319-25091-5_13

Vancouver

Kragelund C, Reibel J, Pedersen AML. Management of Patients with Oral Candidiasis. In Pedersen AML, editor, Oral Infections and General Health : From Molecule to Chairside. 1 ed. Heidelberg: Springer. 2016. p. 137-144 https://doi.org/10.1007/978-3-319-25091-5_13

Author

Kragelund, Camilla ; Reibel, Jesper ; Pedersen, Anne Marie Lynge. / Management of Patients with Oral Candidiasis. Oral Infections and General Health : From Molecule to Chairside. editor / Anne Marie Lynge Pedersen. 1. ed. Heidelberg : Springer, 2016. pp. 137-144

Bibtex

@inbook{41a5a0b88927467582dbbe822183a58f,
title = "Management of Patients with Oral Candidiasis",
abstract = "Oral candidal infections are medically treated with antifungal agents. In the fungal cell membrane, steroid ergosterol is the target of the antifungals on the market, but similarity with the human cell membrane may cause host toxicity and unintended reactions. Management of oral candidiasis depends on several factors, some are host-sensitive parameters, systemic diseases and drug exposure, and others are infection-sensitive parameters, duration of the infection and the virulence of the infecting Candida species. Treatment failure might be associated with acquired or native azole resistance in particular in patients with recurrent oral candidiasis. This risk can be reduced if different types of antifungal drugs are used over time or are combined. This chapter focuses on antifungal treatment of the medically compromised patient with oral candidiasis by highlighting the advantages and disadvantages of different antifungals.",
author = "Camilla Kragelund and Jesper Reibel and Pedersen, {Anne Marie Lynge}",
year = "2016",
month = jan,
doi = "10.1007/978-3-319-25091-5_13",
language = "English",
isbn = "978-3-319-25089-2",
pages = "137--144",
editor = "Pedersen, {Anne Marie Lynge}",
booktitle = "Oral Infections and General Health",
publisher = "Springer",
address = "Switzerland",
edition = "1",

}

RIS

TY - CHAP

T1 - Management of Patients with Oral Candidiasis

AU - Kragelund, Camilla

AU - Reibel, Jesper

AU - Pedersen, Anne Marie Lynge

PY - 2016/1

Y1 - 2016/1

N2 - Oral candidal infections are medically treated with antifungal agents. In the fungal cell membrane, steroid ergosterol is the target of the antifungals on the market, but similarity with the human cell membrane may cause host toxicity and unintended reactions. Management of oral candidiasis depends on several factors, some are host-sensitive parameters, systemic diseases and drug exposure, and others are infection-sensitive parameters, duration of the infection and the virulence of the infecting Candida species. Treatment failure might be associated with acquired or native azole resistance in particular in patients with recurrent oral candidiasis. This risk can be reduced if different types of antifungal drugs are used over time or are combined. This chapter focuses on antifungal treatment of the medically compromised patient with oral candidiasis by highlighting the advantages and disadvantages of different antifungals.

AB - Oral candidal infections are medically treated with antifungal agents. In the fungal cell membrane, steroid ergosterol is the target of the antifungals on the market, but similarity with the human cell membrane may cause host toxicity and unintended reactions. Management of oral candidiasis depends on several factors, some are host-sensitive parameters, systemic diseases and drug exposure, and others are infection-sensitive parameters, duration of the infection and the virulence of the infecting Candida species. Treatment failure might be associated with acquired or native azole resistance in particular in patients with recurrent oral candidiasis. This risk can be reduced if different types of antifungal drugs are used over time or are combined. This chapter focuses on antifungal treatment of the medically compromised patient with oral candidiasis by highlighting the advantages and disadvantages of different antifungals.

U2 - 10.1007/978-3-319-25091-5_13

DO - 10.1007/978-3-319-25091-5_13

M3 - Book chapter

SN - 978-3-319-25089-2

SP - 137

EP - 144

BT - Oral Infections and General Health

A2 - Pedersen, Anne Marie Lynge

PB - Springer

CY - Heidelberg

ER -

ID: 162686602